Company Filing History:
Years Active: 2025
Title: The Innovations of Matthew Frigault
Introduction
Matthew Frigault is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of immunology through his innovative work on modified T cells. His research focuses on enhancing the capabilities of T lymphocytes, which play a crucial role in the immune response.
Latest Patents
Frigault holds a patent for "Modified T cells and methods of their use." This invention provides modified isolated T lymphocytes that have reduced or eliminated expression of the T Cell Receptor. The modifications involve the expression of a protein comprising US6, UL40 viral protein and signal peptide, and UL18. This advancement has the potential to improve therapeutic strategies in treating various diseases.
Career Highlights
Matthew Frigault is associated with The General Hospital Corporation, where he continues to push the boundaries of medical research. His work has garnered attention for its innovative approach to modifying T cells, which could lead to breakthroughs in cancer treatment and other immunological disorders.
Collaborations
Frigault collaborates with notable colleagues, including Marcela V Maus and Mark Cobbold. Their combined expertise enhances the research environment and fosters innovative solutions in the field of immunology.
Conclusion
Matthew Frigault's contributions to the field of immunology through his patented innovations demonstrate his commitment to advancing medical science. His work on modified T cells holds promise for future therapeutic applications.